Relcobatinib

(Synonyms: Relcobatinibum)

Relcobatinib (Relcobatinibum) is a ABL1 kinase inhibitor with an IC50 of 12.7 nM against wild-type ABL1 and an IC50 of 43.5 nM against the ABL1T315I mutant. Relcobatinib inhibits the phosphorylation of CRKL. Relcobatinib exhibits anticancer activity against chronic myeloid leukemia. Relcobatinib can be used in studies related to chronic myeloid leukemia.

For research use only. We do not sell to patients.

  • CAS No.: 2767305-95-1
  • Formula: C18H12D6FN5O3
  • Molecular Weight:377.40
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Bcr-Abl Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00